RELMADA THERAPEUTICS, INC. Increase (Decrease) in Accrued Taxes Payable
RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Accrued Taxes Payable of $275 for the 24-month period ending 2013-05-31, per its 10-Q filed 2013-07-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2013-07-12
- 2013-05-31: Increase (Decrease) in Accrued Taxes Payable 9 month $275.00; Increase (Decrease) in Accrued Taxes Payable 24 month $275.00.
| Period end | Increase (Decrease) in Accrued Taxes Payable 9 month | Increase (Decrease) in Accrued Taxes Payable 24 month |
|---|---|---|
| 2013-05-31 | $275.00 10-Q · filed 2013-07-12 | $275.00 10-Q · filed 2013-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |